Skip to main content
Clinical Trials/JPRN-UMIN000002704
JPRN-UMIN000002704
Completed
Phase 1

Pharmacotherapy for behavioral symptoms of frontotemporal dementia - Pharmacotherapy for frontotemporal dementia

HO Kikuchi Hospital0 sites25 target enrollmentNovember 4, 2009

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Not specified
Sponsor
HO Kikuchi Hospital
Enrollment
25
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 4, 2009
End Date
October 1, 2009
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
HO Kikuchi Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) delirium due to metabolic intoxication and drug use; (2\) alcoholism, stroke, depression, manic state, and schizophrenia before the onset of FTD; (3\) previous use of Yokukansan, major tranquilizers, and antidepressants; (4\) neoplastic disease and acute inflammation

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
Pharmacotherapy for behavioral symptoms of frontotemporal dementiaFrototemporal dementia
JPRN-UMIN000003241ational Hospital Organization Kikuchi Hospital25
Completed
Not Applicable
onpharmacologic intervention for Behavioral and psychological symptoms of dementia using the positive emotions of patients with Alzheimer's diseaseAlzheimer&#39s disease
JPRN-UMIN000036393Kyoto Prefectural University of Medicine30
Completed
Phase 3
Spontaneous Urinary Stone Passage ENabled by Drugs
ISRCTN69423238niversity of Aberdeen (UK)1,200
Active, not recruiting
Phase 1
se of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: a multicentre placebo controlled randomised trial of a calcium channel blocker(nifedipine)and an alpha blocker(tamsulosin) - The SUSPEND trial - Symptomatic ureteric stone passage enabled by drugs (SUSPEND)se of drug therapy in the management of symptomatic ureteric stones in hospitalised adults: multicentre placebo controlled randomised trial of a calcium channel blocker(nifedipine) and an alpha blocker (tamsulosin).
EUCTR2010-019469-26-GBniversity of Aberdeen1,167
Active, not recruiting
Not Applicable
Sympthomatic and prophylactic treatment of drug induced oral dryness in elderly patients with high drug consumption. - Drug induced oral drynessOral dryness is a common problem with serious consquences, especially among elderly individuals. The most common reason for oral dryness is drug consumption. Research has shown that an individual with more than 5 prescribed drug is at risk for oral problems. Drug consumtion is increasing among elderly, mostly due to lack in cooperation in the health care system. Oral dryness have impact on quality of life with eating difficulties and an increased rsik for dental caries.
EUCTR2006-001468-21-SEKarolinska Institutet